175 related articles for article (PubMed ID: 19513576)
1. Bone turnover in patients with endogenous Cushing's syndrome before and after successful treatment.
Szappanos A; Toke J; Lippai D; Patócs A; Igaz P; Szücs N; Füto L; Gláz E; Rácz K; Tóth M
Osteoporos Int; 2010 Apr; 21(4):637-45. PubMed ID: 19513576
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study.
Di Somma C; Pivonello R; Loche S; Faggiano A; Klain M; Salvatore M; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2003 Mar; 58(3):302-8. PubMed ID: 12608935
[TBL] [Abstract][Full Text] [Related]
3. Quantitative ultrasound of bone and markers of bone turnover in Cushing's syndrome.
Cortet B; Cortet C; Blanckaert F; d'Herbomez M; Marchandise X; Wémeau J-L ; Decoulx M; Dewailly D
Osteoporos Int; 2001; 12(2):117-23. PubMed ID: 11303711
[TBL] [Abstract][Full Text] [Related]
4. Effect of single doses of dexamethasone and adrenocorticotrop hormone on serum bone markers in healthy subjects and in patients with adrenal incidentalomas and Cushing's syndrome.
Majnik J; Szücs N; Patócs A; Tóth M; Balogh K; Varga I; Gláz E; Rácz K
J Endocrinol Invest; 2004 Sep; 27(8):747-53. PubMed ID: 15636428
[TBL] [Abstract][Full Text] [Related]
5. Severe impairment of bone mass and turnover in Cushing's disease: comparison between childhood-onset and adulthood-onset disease.
Di Somma C; Pivonello R; Loche S; Faggiano A; Marzullo P; Di Sarno A; Klain M; Salvatore M; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2002 Feb; 56(2):153-8. PubMed ID: 11874405
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease.
Di Somma C; Colao A; Pivonello R; Klain M; Faggiano A; Tripodi FS; Merola B; Salvatore M; Lombardi G
Clin Endocrinol (Oxf); 1998 May; 48(5):655-62. PubMed ID: 9666879
[TBL] [Abstract][Full Text] [Related]
7. Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.
Sartorio A; Conti A; Ferrario S; Passini E; Re T; Ambrosi B
Postgrad Med J; 1996 Jul; 72(849):419-22. PubMed ID: 8935602
[TBL] [Abstract][Full Text] [Related]
8. Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study.
Kristo C; Jemtland R; Ueland T; Godang K; Bollerslev J
Eur J Endocrinol; 2006 Jan; 154(1):109-18. PubMed ID: 16381999
[TBL] [Abstract][Full Text] [Related]
9. Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing's syndrome.
Füto L; Toke J; Patócs A; Szappanos A; Varga I; Gláz E; Tulassay Z; Rácz K; Tóth M
Osteoporos Int; 2008 Jul; 19(7):941-9. PubMed ID: 18043854
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Mild Autonomous Cortisol Secretion on Bone Turnover Markers.
Athimulam S; Delivanis D; Thomas M; Young WF; Khosla S; Drake MT; Bancos I
J Clin Endocrinol Metab; 2020 May; 105(5):1469-77. PubMed ID: 32154561
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypercortisolism on bone mineral density and bone metabolism: A potential protective effect of adrenocorticotropic hormone in patients with Cushing's disease.
Guo W; Li F; Zhu C; Wang B; Wang K; Dai C; Jia H; Wei H; He Q; Cui J; Yuan M; Tang S; Liu W; Zhu T; Gao Z; Zheng F; Ma Z; Qu H; Zhu M
J Int Med Res; 2018 Jan; 46(1):492-503. PubMed ID: 28851260
[TBL] [Abstract][Full Text] [Related]
13. The 83,557insA variant of the gene coding 11β-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing's syndrome.
Szappanos A; Patócs A; Gergics P; Bertalan R; Kerti A; Acs B; Feldmann K; Rácz K; Tóth M
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):79-84. PubMed ID: 21111044
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Biochemical Remission on Bone Metabolism in Cushing's Syndrome: A 2-Year Follow-Up Study.
Braun LT; Fazel J; Zopp S; Benedix S; Osswald-Kopp A; Riester A; Rubinstein G; Seidensticker M; Beuschlein F; Drey M; Bidlingmaier M; Schmidmaier R; Reincke M
J Bone Miner Res; 2020 Sep; 35(9):1711-1717. PubMed ID: 32315096
[TBL] [Abstract][Full Text] [Related]
15. Persistent increase of osteoprotegerin levels after cortisol normalization in patients with Cushing's syndrome.
Camozzi V; Sanguin F; Albigier N; Scaroni C; Mantero F; Zaninotto M; Frigo A; Piccolo M; Luisetto G
Eur J Endocrinol; 2010 Jan; 162(1):85-90. PubMed ID: 19793762
[TBL] [Abstract][Full Text] [Related]
16. Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas.
Osella G; Terzolo M; Reimondo G; Piovesan A; Pia A; Termine A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1997 Oct; 82(10):3303-7. PubMed ID: 9329358
[TBL] [Abstract][Full Text] [Related]
17. Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus.
Liu XX; Jiang L; Liu Q; Zhang J; Niu W; Liu J; Zhang Q
J Diabetes Res; 2020; 2020():6191468. PubMed ID: 32851096
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.
Karavitaki N; Ioannidis G; Giannakopoulos F; Mavrokefalos P; Thalassinos N
Clin Endocrinol (Oxf); 2004 Feb; 60(2):264-70. PubMed ID: 14725690
[TBL] [Abstract][Full Text] [Related]
19. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
Yap LB; Turner HE; Adams CB; Wass JA
Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
[TBL] [Abstract][Full Text] [Related]
20. Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome.
Godang K; Ueland T; Bollerslev J
Eur J Endocrinol; 1999 Aug; 141(2):126-31. PubMed ID: 10427155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
